Panoramic Health and West Coast Kidney Institute Launch Specialized Research Institute for Cardio-Renal-Metabolic Trials
核心洞察
Panoramic Science (搜索) and West Coast Kidney Institute (搜索) have launched the Concord Cardio-Renal Research Institute (搜索) in California's Bay Area to accelerate enrollment and execution of cardio-renal-metabolic clinical trials.
The purpose-built facility features 2,000 square feet of dedicated research space with advanced capabilities including infusion services, pharmacokinetic sampling, and secure drug storage to support complex early-stage study designs.
The institute is led by experienced nephrologists Dr. Edward Kim and Dr. Rohit Sharma, and represents Panoramic Science (搜索)'s third Bay Area site within their growing national network of over 20 research locations.
Panoramic Science (搜索), the clinical research division of Panoramic Health (搜索), and West Coast Kidney Institute (搜索) announced the launch of the Concord Cardio-Renal Research Institute (搜索), a specialized clinical research facility designed to accelerate cardio-renal-metabolic trial enrollment and execution. The Bay Area-based institute represents a strategic expansion aimed at addressing enrollment challenges that have historically slowed drug development in this therapeutic area.
Advanced Research Infrastructure
The Concord facility spans approximately 2,000 square feet of dedicated research space, featuring three research exam rooms, infusion capabilities, pharmacokinetic sampling, lab processing and shipping facilities, and secure investigational drug storage. The site is specifically equipped to support extended observation visits and IV-based therapies, enabling execution of complex and earlier-stage study designs that require sophisticated infrastructure.
"We're focused on connecting complex patients with the latest investigational therapies while helping address systemic enrollment challenges that slow drug development," said Lisa Kiehne, President of Panoramic Science (搜索). "We are excited to establish the Concord site as a center of excellence that brings together clinical expertise, infrastructure, and access to better serve patients and support our sponsor partners."
Integrated Clinical Model
The research institute operates within a multidisciplinary medical office setting, providing immediate access to nephrology and cardiology care, as well as supportive services including nutritional counseling and higher-acuity care when clinically indicated. This integrated approach supports both patient safety and efficient trial execution tailored to the specific requirements of cardiovascular, renal, and metabolic studies.
The site is led by experienced investigators Dr. Edward Kim and Dr. Rohit Sharma, both board-certified nephrologists with extensive clinical research experience across kidney and cardiovascular disease (搜索). Dr. Michael Murphy serves as the site's investigator for access- and device-related trials, providing additional specialized expertise.
Strategic Network Expansion
The Concord Cardio-Renal Research Institute (搜索) represents Panoramic Science (搜索)'s third research site in the Bay Area and forms part of a growing national network exceeding 20 sites across the United States. This expanding footprint enables pharmaceutical sponsors to scale trials more efficiently while maintaining consistent quality and clinical standards.
"Partnering with Panoramic Health (搜索) allows us to bring a higher level of research capability to our patients and our community," said Dr. Sharma of West Coast Kidney Institute (搜索). "This site is designed to deliver both access and performance, connecting patients to innovative therapies while giving sponsors a reliable, high-quality research partner."
Addressing Market Needs
The institute's launch comes as the pharmaceutical industry faces persistent challenges in cardio-renal-metabolic trial enrollment, with complex patient populations requiring specialized care coordination. Panoramic Health (搜索)'s integrated kidney care model, which supports hundreds of thousands of patients across aligned nephrology practices nationwide, provides direct access to a large, clinically diverse patient population suitable for these specialized trials.
The facility's purpose-built design specifically addresses the complex protocol requirements common in cardio-renal-metabolic research, where patients often present with multiple comorbidities requiring coordinated specialist care and extended monitoring capabilities.